Enzyme immunoassay for the qualitative determination of specific antibodies to  omalizumab (Xolair®) in human serum and plasma.

This kit has been especially developed for the qualitative determination of omalizumab in serum and plasma samples.

The Matriks Biotek Antibody to omalizumab (Xolair®) Enzyme-Linked-ImmunoSorbentAssay (ELISA) Kit is intended for the qualitative determination of antibodies to omalizumab (Xolair®) in serum and plasma. It is for professional use only. Measurement of biological drug trough levels and antibody to biological drug gained high importance during the course of treatment. These measurements enable dose adjustments and switch to another class of biological drug when necessary.

All SHIKARI® ELISA kits are suitable for biosimilar work. 

All SHIKARI® ELISA kits are produced under ISO 13485 quality system and have CE IVD mark.

For technical inquiry, please contact techsupport@matriksbiotek.com

Matriks Biotek® is a biotechnology company that conducts research on biotechnology, developing products and offering its products at a global scale helping people to lead a better life.